The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
INTELLIA THERAPEUTICS INC COM 45826J105 727 10,000 SH   SOLE   10,000 0 0
SNAP INC CL A 83304A106 5,404 150,160 SH   SOLE   0 0 150,160
SYNLOGIC INC COM 87166L100 6,364 2,651,963 SH   SOLE   2,651,963 0 0
SPERO THERAPEUTICS INC COM 84833T103 11,980 1,376,968 SH   SOLE   1,376,968 0 0
COGENT BIOSCIENCES INC COM 19240Q201 6,867 916,832 SH   SOLE   916,832 0 0
SURFACE ONCOLOGY INC COM 86877M209 8,660 2,945,453 SH   SOLE   2,945,453 0 0
SKILLZ INC COM 83067L109 68,730 22,909,859 SH   SOLE   22,909,859 0 0